Skip to main content
Article
Safety of Ixekizumab in Patients with Psoriatic Arthritis: Results from a Pooled Analysis of Three Clinical Trials.
Arthritis Care and Research (2019)
  • Philip Mease, Swedish Medical CenterUniversity of Washington Seattle WAUSA
  • Euthalia Roussou, King George Hospital Goodmayes EssexUnited Kingdom
  • Gerd-Rüdiger Burmester, Humboldt University of Berlin
  • Philippe Goupille, François Rabelais University
  • Alice Gottlieb, New York Medical College
  • Susan R Moriarty, Eli Lilly and Company
  • Olivier Benichou, Eli Lilly and Company
  • David H Adams, Eli Lilly and Company
  • Wen Xu, Eli Lilly and Company
  • Peter Nash, University of Queensland
Publication Date
February 12, 2019
DOI
10.1002/acr.23738
Citation Information
Philip Mease, Euthalia Roussou, Gerd-Rüdiger Burmester, Philippe Goupille, et al.. "Safety of Ixekizumab in Patients with Psoriatic Arthritis: Results from a Pooled Analysis of Three Clinical Trials." Arthritis Care and Research (2019)
Available at: http://works.bepress.com/philip-mease/314/